Anaemia, erythrocytosis, and empagliflozin in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.

Eur Heart J

Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.

Published: December 2024

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehae864DOI Listing

Publication Analysis

Top Keywords

anaemia erythrocytosis
4
erythrocytosis empagliflozin
4
empagliflozin heart
4
heart failure
4
failure preserved
4
preserved ejection
4
ejection fraction
4
fraction emperor-preserved
4
emperor-preserved trial
4
anaemia
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!